Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - clindamycin (unii: 3u02el437c) (clindamycin - unii:3u02el437c) - clindamycin and benzoyl peroxide gel, 1%/5% is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide gel, 1%/5% is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - clindamycin (unii: 3u02el437c) (clindamycin - unii:3u02el437c) - clindamycin and benzoyl peroxide gel, 1%/5% is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide gel, 1%/5% is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

physicians total care, inc. - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - clindamycin 10 mg in 1 g - benzaclin topical gel is indicated for the topical treatment of acne vulgaris. benzaclin topical gel is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

bryant ranch prepack - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm), clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is indicated for the topical treatment of acne vulgaris in patients 12 years or older. clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is contraindicated in those individuals who have shown hypersensitivity to clindamycin, benzoyl peroxide, any components of the formulation, or lincomycin. anaphylaxis, as well as allergic reactions leading to hospitalization, has been reported in postmarketing use with clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5%. [see postmarketing experience (6.2). ] clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% is contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. [see warnings and precautions (5.1). ] risk summary there are no available data on clindamycin phosphate and benzoyl peroxide gel, 1.2%/2.5% use in pregnant women to evaluate a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcome

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin and benzoyl peroxide topical gel, 1%/5% is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide topical gel, 1%/5% is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin and benzoyl peroxide topical gel, 1%/5% is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide topical gel, 1%/5% is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

remedyrepack inc. - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin and benzoyl peroxide gel, 1%/5% is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide gel, 1%/5% is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

remedyrepack inc. - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin and benzoyl peroxide topical gel, 1%/5% is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide topical gel, 1%/5% is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

stiefel laboratories inc - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - duac® (clindamycin phosphate and benzoyl peroxide) gel, 1.2%/5% is indicated for the topical treatment of inflammatory acne vulgaris in patients 12 years and older. duac gel has not been demonstrated to have any additional benefit when compared with benzoyl peroxide alone in the same vehicle when used for the treatment of non-inflammatory acne. duac gel is contraindicated in those individuals who have shown hypersensitivity to clindamycin, benzoyl peroxide, any components of the formulation, or lincomycin. anaphylaxis, as well as allergic reactions leading to hospitalization, has been reported in postmarketing use with duac gel. [see adverse reactions (6.2).] duac gel is contraindicated in those individuals with a history of regional enteritis, ulcerative colitis, pseudomembranous colitis, or antibiotic-associated colitis [see warnings and precautions (5.1)]. pregnancy category c. there are no adequate and well-controlled studies in pregnant women treated with duac gel. duac gel should be used during pregnan

Israel - Tiếng Anh - Ministry of Health

padagis israel agencies ltd, israel - benzoyl peroxide as hydrous; clindamycin as phosphate - gel - clindamycin as phosphate 1 %w/w; benzoyl peroxide as hydrous 5 %w/w - clindamycin - clindamycin - mild to moderate acne vulgaris, particulary inflammatory lesions.